SmartDose® Gen. I 3.5mL Drug Delivery Platform

Leading the way with integrated containment and delivery solutions

The first combination product that incorporates the SmartDose® Generation I (Gen. I) drug delivery platform has been approved by the U.S. Food and Drug Administration (FDA). The SmartDose Gen. I device offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.

SmartDose Gen I Logo


  • User loaded, subcutaneous self-administration
  • Ability to deliver high volume and high viscosity drug products 
  • Connectivity capable 
  • Easy to use, intuitive design 
  • Visual, tactile and audible feedback to boost user confidence 
  • Training solutions available for a seamless onboarding experience
  • Address a variety of delivery times through adaptable, pre-programmable technology 
  • Enables less painful injections through pre-programmable delivery times 
  • Multiple published studies* indicate lower pain with customizable delivery rates
  • Installed capacity at multiple manufacturing sites 
  • Regulatory, Quality and Human Factors expertise to support your development

SmartDose Gen I Technical Specifications

SmartDose Gen I Logo









SmartDose® is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West Pharmaceutical Services, Inc.

West markets SmartDose® as a multi-component system only.  Final assembly of the prefilled component is completed by the pharmaceutical company.

SelfDose™ is a trademark of West Pharmaceutical Services, Inc. 

Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.